Example of student autopsy report

 

SUMMARY OF CLINICAL HISTORY:

 

The patient was a 66 year old hypertensive white male with a history of orthotopic heart transplantation for severe ischemic heart disease.  His immuno-suppressive regimen consisted of FK-506, Imuran, and Prednisone.  Endomyocardial biopsies one, two and six months after transplantation showed no rejection.  His post-transplant course was complicated by recurrent cytomegalovirus (CMV) enteritis, treated with gancyclovir.  Nine months after transplantation he presented to the hospital with anorexia and weight loss.  CT scan of the abdomen showed circumferential thickening of the terminal ileum and duodenum.  Endoscopic biopsy showed polymorphic B cell lymphoma; bone marrow biopsy was negative for lymphoma.  He was treated with Rituxan anti-CD20 polyclonal antibody, and the FK-506 was discontinued, with apparent remission of his lymphoma by CT scan.  Three months later, he had developed clinical signs of heart failure, including pleural effusion (cytology and cultures negative) and it was felt that allograft function was declining.  Endomyocardial biopsies eleven and 14 months post-transplant showed mild to moderate acute cellular rejection. 

 

Fifteen months post-transplant, the patient was admitted to the SICU at UTMB with complaints of malaise, anorexia, and abdominal pain for 3-4 days.  On physical exam, he was afebrile with systolic blood pressures in the 60’s and heart rates in the 40’s.  There was right upper quadrant pain on palpation.  Ultrasound of the gallbladder showed thickening of the wall and pericholecystic fluid collection.  The clinical impression was sepsis due to acute cholecystitis.  At 23:00 on the same day, the patient became pulseless and cyanotic.  CPR was initiated and the patient was intubated.  After 24 hours resuscitation and IV antibiotics, a laparoscopic cholecystectomy was performed for suspected acute cholecystitis.  Pathology showed chronic cholecystitis and cultures from the blood and gallbladder were negative.  During the subsequent hospitalization, the patient’s heart function deteriorated, with EKG revealing second degree heart block (Mobitz I), low voltage QRS, and T wave inversions anteriorly.  Echocardiogram revealed an ejection fraction of 25-30%.  He required intermittent intra-aortic balloon pump support and pressors.  He developed acute renal insufficiency (BUN 60 mg/dl and creatinine 3.28 mg/dl) thought to be due to cardiogenic shock.  He was re-started on FK-506.  A Hickman catheter was placed in the right subclavian vein for long term IV access, and he was discharged to home hospice after his cardiovascular status was stabilized.  He died 3 days later.   A limited autopsy was performed approximately 6 hours after death.


 

DESCRIPTION OF GROSS LESIONS

 

EXTERNAL EXAMINATION: The body is that of a 66 year old well developed, well nourished male.  There is no peripheral edema of the extremities.  There is extensive ecchymosis and hemorrhage around the shoulders, the left inguinal region, and both arms.  There is hemorrhage of the conjunctiva of the right eye.  A well healed, 21 cm median sternotomy scar is seen.

 

INTERNAL EXAMINATION (BODY CAVITIES)

The right pleural cavity contains 700 cc of clear yellow fluid.  The left pleural cavity is obliterated by dense fibrous adhesions.  The pericardial sac shows surgical changes and fibrosis.  There are 600 cc of clear straw colored fluid in the peritoneal cavity.

 

HEART:  The patient is status post orthotopic heart transplant, with intact and unremarkable surgical anastomoses at the left and right atria, pulmonary trunk, and aorta.  The allograft heart is enlarged and globular in shape, weighing 600 gm (normal male 270-360 gm).  The pericardium is fibrotic and adherent to the heart.  The epicardial fat is firm diffusely.  A section of myocardium is stained with TTC to identify acute necrosis, but no distinct lesions are seen.  The remaining myocardium is red-brown with a somewhat mottled appearance.  The endocardium is white, with several petechiae.  A thickened, white area of endocardium is seen in the right ventricle, indicating possible previous biopsy sites.  The left ventricle is 1.8 cm thick (normal 1-1.8 cm) and the right ventricle is 0.3 cm thick (normal 0.25-0.3 cm).  The valves are normal, with delicate cusps and leaflets.  The foramen ovale is closed.  The coronary circulation is left dominant.  The coronary arteries reveal only mild atherosclerosis, with a maximum of 30% stenosis by plaque.  There is an occlusive red thrombus in the right coronary artery, 2.5 cm distal to its ostium; there is no associated underlying atherosclerotic plaque. 

 

AORTA:  There are severe atherosclerotic changes with ulcerated, calcified plaques in the abdominal aorta.

 

LUNGS:  The combined weight of the lungs is 1950 gm (normal male 820 gm).  The lung parenchyma is dark red, and foamy fluid exudes from the cut surface.  The bronchi are normal.  Several small peripheral thromboemboli are found in pulmonary artery branches.

 

GASTROINTESTINAL SYSTEM: The esophagus has several discrete, “punched out” appearing oval ulcers, measuring up to 1.5 cm in maximal dimension.  The stomach is grossly normal, with no evidence of tumor or ulcer.  Two large ulcers with thickened edges are seen in the duodenum, near the ampulla of Vater.  These measure 2.0-2.5 cm in maximal dimension.   The pancreas shows a normal lobular cut surface.  A 2.6 cm diameter firm nodule is seen within the wall of the jejunum.  A 1.2 cm diameter, irregular ulcer is seen in the terminal ileum.  The large intestine shows numerous diverticula.  The appendix is present and unremarkable.  The liver weighs 1930 gm (normal male 1400-1900 gm) and has a cut surface with alternating dark and light areas, resembling a nutmeg pattern of chronic passive congestion.  There is no significant fibrosis grossly.  The gallbladder is surgically absent.  A 2.5 cm diameter ill-defined area of induration with central purulent material is seen in the soft tissue at the surgical site near the porta hepatis.

 

RETICULOENDOTHELIAL SYSTEM: The spleen is slightly enlarged, weighing 250 gm (normal 125-195 gm).  The spleen is firm, and cut surface reveals a 0.5x 0.4x 0.3 cm wedge-shaped pale area of infarction.  Lymph nodes throughout the body are grossly unremarkable. 

 

GENITOURINARY SYSTEM:

The right kidney weighs 150 gm and the left weighs 140 gm (normal 125-170 gm).  There is a 1 cm diameter white, firm nodule in the left renal cortex.  The bladder and ureters are normal.  The prostate is not enlarged. 

 

ENDOCRINE SYSTEM: 

The adrenal glands have normal conformation and position.  The thyroid gland is not examined because of limitations of the autopsy.

 

 

 

 

 


MICROSCOPIC DESCRIPTION

 

HEART AND CORONARY ARTERIES: Within the myocardium, there are many areas where myocytes have been destroyed and replaced by granulation tissue.  A few areas of wavy fibers are seen, indicating acute ischemic necrosis.  No lymphocytes are seen in the myocardial interstitium and there is no acute cellular rejection.  No viral inclusions are seen.  Arterioles are normal.  However large epicardial coronary arteries show marked concentric thickening of the intima by pale slightly blue staining connective tissue.  A layer of fibrin is seen lining the endothelium.  The right coronary artery contains an occlusive thrombus, with no evidence of fibroblast ingrowth.  A few lymphocytes are seen within the media and intima of the vessels.  These changes indicate severe vascular rejection.

 

LUNGS:  There is a moderate amount of proteinaceous fluid within alveoli (edema).  Alveolar capillaries are markedly congested.  Scattered type II pneumocytes are enlarged with prominent basophilic nuclear inclusions, indicating cytomegalovirus (CMV) cytopathic effect.

 

LIVER:  There is marked centrilobular congestion with sinusoidal dilatation and hepatocyte atrophy. 

 

SPLEEN:  An area of coagulation necrosis is seen, which is surrounded by hemorrhage.  The amount of white pulp is diminished.

 

SOFT TISSUE AT PORTA HEPATIS: Sections show fibroadipose tissue with liquefactive necrosis with numerous neutrophils and surrounding fibrosis (abscess).  There are numerous pseudohyphae, consistent with candida species, seen on silver stained sections.

 

ESOPHAGUS:  There are numerous ulcers with infiltration of lymphocytes and neutrophils at the base.  Numerous cells with CMV inclusions are seen in the submucosa. 

 

NODULE IN JEJUNUM: The nodule consists of ectopic pancreatic tissue that shows chronic inflammation and fibrosis.  Numerous CMV-inclusion bearing cells are seen within the ectopic pancreas.

 

DUODENUM:  Several deep ulcers are seen, with chronic inflammation (lymphocytes) and numerous CMV inclusions in fibroblasts at the ulcer bases.  No lymphoma is seen.

 

ULCER IN ILEUM: Sections show inflammation and CMV infection.

 

KIDNEYS:  The nodule in the left kidney is composed of amorphous necrotic debris with surrounding fibrosis and numerous hemosiderin-laden macrophages.  Special stains are negative for bacteria, acid fast bacilli, and fungi.

 

 

 

CLINICOPATHOLOGIC CORRELATION:

 

This patient died 18 months after cardiac transplantation for severe ischemic heart disease.

 

The autopsy showed severe vascular rejection in the allograft.  This form of rejection is characterized by vasculitis, endotheliitis, and fibrinoid necrosis of arteries and arterioles with superimposed thrombosis.  Because of these vascular changes, there were innumerable foci of ischemic necrosis of varying ages within both ventricles.  This led to severe heart dysfunction, with chronic passive congestion of the lungs and liver.  The presenting symptoms and signs of hypotension and right upper quadrant abdominal pain likely resulted from heart failure with chronic passive congestion of the liver, rather than sepsis and acute cholecystitis.  The cause of death is heart failure due to acute vascular rejection.

 

This form of rejection differs from acute cellular rejection, in which myocytes are attacked by lymphocytes.  Endomyocardial biopsy can detect acute cellular rejection, but not acute vascular rejection, since blood vessels are not sampled.  This could explain the discrepancy between the patient’s worsening graft function and the appearance of only mild rejection by biopsy.

 

Infectious complications may supervene in patients with immunosuppression post transplantation.  CMV had been a problem for this patient in his post-transplant course.  At autopsy, there was disseminated CMV infection, involving the lungs, esophagus, duodenum, jejunum, ileum, and ectopic pancreas within the jejunum.  There was no evidence of lymphoma in the gastrointestinal tract or elsewhere at autopsy.  An additional infection found at autopsy was candida infection of the cholecystectomy site.  This infection likely started after the cholecystectomy; this opinion is based on the negative surgical pathology and culture results from the cholecystectomy.  Also, the histologic appearance of the lesion is consistent with the nearly 3 week interval between surgery and death.  A necrotic nodule was found in the kidney, but the cause of this could not be determined.  There were several small peripheral thromboemboli in the pulmonary vasculature, but these probably did not play a major role in his demise.  Diverticulosis of the colon was an incidental finding. 

 

In summary, this patient died of heart failure from severe acute vascular rejection of his cardiac allograft.  Contributing factors included disseminated CMV infection.  The manner of death is natural.


BASIC SCIENCE QUESTION:

 

WHAT ARE THE IMMUNOLOGIC MECHANISMS OF VASCULAR REJECTION?

 

The most typical pattern of rejection in cardiac allografts is acute cellular rejection, characterized by myocardial infiltration by lymphocytes; it is this pattern of cellular rejection that is assessed in endomyocardial biopsies (1).  However, it has been increasingly recognized that in some patients, allograft failure is due to vascular rejection, characterized histologically by endothelial and vascular wall inflammation, ultimately leading to accelerated graft atherosclerosis.  This form of rejection may occur in the absence of acute cellular rejection (2).  Whereas acute cellular rejection is believed to represent T cell-mediated attack against alloantigens on myocytes, vascular rejection has been associated with deposition of immunoglobulin and complement in vessel walls, hence it is the hypothesized result of humoral immune attack against vessel wall structures (2).  The pathogenesis of vascular rejection is not understood, but anti-donor antibodies, as against HLA antigens, have been implicated (3).  This would imply a type II hypersensitivity mechanism.  Binding of antibody to donor vessel wall (endothelial) antigens would lead to activation of complement by the classical pathway.  Complement activation in turn leads to lysis of membranes by membrane attack complex assembly, and to recruitment of inflammatory cells (neutrophils) by anaphylotoxins C3a and C5a.  It is interesting that an association has been reported between CMV infection and the development of anti-endothelial antibodies (4).  Although these authors did not show a relationship between anti-endothelial antibodies and vascular rejection, it seems possible that such antibodies could cause vascular damage by the mechanisms described above.  This scenario may well have been important in this patient’s course.

 

In addition to evidence suggesting the involvement of humoral mechanisms in vascular rejection, a recent study of cardiac allografts from autopsy revealed a pattern of vascular rejection suggestive of T-cell mediated immune attack directed against smooth muscle cells of the media of epicardial and intramyocardial arteries (5).  In approximately half the patients studied with vascular rejection, T cell infiltrates as well as immunoglobulin and complement deposits were identified in vessel walls.  However, these deposits were seen in the media of the arteries, rather than the intima, as reported by others.  These observations suggest that vascular smooth muscle cells may be a target for both humoral and cellular immune mechanisms of rejection.  In this study, the presence of vasculitis did not correlate with the intensity of cellular rejection in the myocardium.  These authors suggest that evidence of medial lymphocytic vasculitis in endomyocardial biopsies is indicative of diffuse vascular involvement that is likely to involve epicardial vessels, and may warrant increased immunosuppression, even in the absence of acute cellular rejection. 

 

In summary, it appears that both humoral and cellular mechanisms may be involved in the distinct pattern of vascular rejection in cardiac allografts. 

 

 

1.      Billingham, ME et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection.  J Heart Transpl 9:587 (1990)

 

2.      Hammond, EH et al.  Vascular rejection and its relationship to allograft coronary artery disease.  Journal of Heart and Lung Transplantation.  11:S111-9 (1992).

 

3.      McCarthy JF, et al.  Vascular rejection and its relationship to allograft coronary artery disease.  Transplant Proc 31:160 (1999)

 

4.      Toyoda M et al.  Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients.  Transplant Immunol 5:104-11 (1997)

 

5.      Higuchi M et al.  Histological evidence of concomitant intramyocardial and epicardial vasculitis in necropsied heart allografts:  A possible relationship with graft coronary arteriosclerosis.  Transplantation 67:1569-1576 (1999).


Sample Cause of Death Worksheet for Autopsy Exercise

Text Box: DO NOT FILE IN MEDICAL RECORD; SEND TO THE AUTOPSY SERVICE.Patient’s Name: _______________________________________

Cause of Death Worksheet: To be completed by certifying physician.

3.  Date of Death

18. Place of Death (check only one)  Hospital:                           Inpatient              ER/Outpatient         DOA

33. Time of Death

34. Printed Name of Certifier:Joanne Smith, MS4                      Pager #

35 Part 1   Enter the diseases, injuries, or complications that caused the death.  Do not enter the mode of dying, such as cardiac or respiratory arrest, shock, or heart failure.  List only one cause on each line.

Interval between onset and death.

Immediate Cause of Death: (final disease or condition resulting in death)

a.       Vascular rejection of cardiac allograft

weeks

Sequentially list conditions, if any, leading to immediate cause.  Enter UNDERLYING CAUSE (disease or injury that initiated events resulting in death) LAST.

b.       Status post heart transplant

18 months

c.       Coronary artery disease

years

d.        

 

Part 2     Other significant conditions contributing to death, but not resulting in the underlying cause given in Part 1.

Disseminated cytomegalovirus infection

36a. Autopsy?

x Yes   No

36b. Were autopsy findings available prior to completion of cause of death?

           x Yes   No

37. Did tobacco use contribute to death?

                 Yes    x Probably

                 No       Unknown

38. Did Alcohol contribute to death?

               Yes       Probably

             x  No       Unknown

39. Was decedent pregnant?

At time of death       Yes    x No    Unknown

Within last 12 mo    Yes    x No    Unknown

40. Manner of Death

xNatural

Accident

Suicide

Homicide

Pending Investigation

Could not be determined

41a. Date of Injury

41b. Time of Injury

                     .M.

41c. Injury at Work?

YES    NO

41d. Place of Injury - at Home, Farm, Street, Factory, Office, etc. (Specify)

41e. Location (Street and number, city or town, state

41f. Describe how injury occurred


Instructions: Print all information.  Do not use abbreviations.

1.       Stamp with patient's ID card or affix Invision label.

2.       Item #3: Provide the date of death.

3.       Item #18: Indicate where death occurred.

4.       Item #33: Provide the time that death is officially pronounced.
Note if organ donor, this is the time of "brain/cardiac death".

5.       Item #34: Printed name of physician that will sign the death certificate.  Please provide your pager number for notification when Death Certificate is ready for signature.

6.       Item 35a-d and Part II: Provide the cause of death.  Follow instructions given in item 35.

7.       Item #36a - 39: Place an "X" for appropriate responses.

8.       Item #40: Physicians may only mark "Natural" for the cause of death.  If a manner of death other than "Natural" is marked, the physician must notify the Medical Examiner of the death.  Note, only the Medical Examiner can sign a

       death certificate with a manner of death other than "Natural".

9.       Items 41a - 41f: Only applies to Medical Examiner cases, and may only be completed by Medical Examiner.

if pt id card or label is unavailable, write date, pt name and uh# in space below

CAUSE OF DEATH WORKSHEET

The University of Texas Medical Branch Hospitals
Galveston, Texas

Rev. 4/3/01